Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Ilan Ben-Shabat; Christoffer Hansson; Malin Sternby Eilard; Christian Cahlin; Magnus Rizell; Per Lindn&#233;r; Jan Mattsson; Roger Olofsson Bagge

doi:10.3791/52490

Journal

/

Medicine

/

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

JoVE Journal
Medicine
Author Produced

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Medicine

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

13,317 Views

•

09:52 min

•

January 25, 2015

DOI:

10.3791/52490-v

DOI:

10.3791/52490-v

•

09:52 min

January 25, 2015

•

1 Views

Ilan Ben-Shabat^1,4, Christoffer Hansson^2,4, Malin Sternby Eilard^3,4, Christian Cahlin^3,4, Magnus Rizell^3,4, Per Lindnér^3,4, Jan Mattsson^1,4, Roger Olofsson Bagge^1,4

¹Department of Surgery,Institute of Clinical Sciences, ²Department of Thoracic Surgery,Institute of Clinical Sciences, ³Transplant Institute,Institute of Clinical Sciences, ⁴Sahlgrenska University Hospital,Sahlgrenska Academy at the University of Gothenburg

Summary

Here, we present a protocol how to perform an isolated liver perfusion (IHP) with melphalan and we also discuss IHP as a treatment option for liver metastases of uveal melanoma.

Explore More Videos

Isolated Hepatic Perfusion IHP Liver Metastases Uveal Melanoma Chemotherapeutic Agent Melphalan Percutaneous Veno-venous Bypass Laparotomy Catheters Hepatic Artery Caval Vein Portal Vein Heart Lung Machine Response Rate Survival

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Automatically Generated

Summary

Automatically generated

Explore More Videos

Related Videos